Harmony Biosciences Holdings (HRMY) Other Non-Current Liabilities (2019 - 2026)

Harmony Biosciences Holdings (HRMY) has 8 years of Other Non-Current Liabilities data on file, last reported at $5.3 million in Q1 2026.

• For the quarter ending Q1 2026, Other Non-Current Liabilities rose 211.17% year-over-year to $5.3 million; the trailing twelve-month figure through Mar 2026 stood at $5.3 million (up 211.17% YoY), and the FY2025 full-year result was $5.6 million, up 188.55% from the prior year.
• Other Non-Current Liabilities fell to $5.3 million in Q1 2026, from $5.6 million in the prior quarter.
• In the past five years, Other Non-Current Liabilities ranged from a high of $5.6 million in Q4 2025 to a low of $1.2 million in Q3 2025.
• A 5-year average of $2.5 million and a median of $2.1 million in 2023 frame the typical range for Other Non-Current Liabilities.
• Across the five-year window, Other Non-Current Liabilities surged 270.4% in 2022 and sank 47.21% in 2023, its largest moves.
• Tracing HRMY's Other Non-Current Liabilities over 5 years: stood at $2.5 million in 2022, then slipped by 15.57% to $2.1 million in 2023, then declined by 7.68% to $1.9 million in 2024, then jumped by 188.55% to $5.6 million in 2025, then dropped by 5.29% to $5.3 million in 2026.
• Business Quant data shows HRMY's Other Non-Current Liabilities at $5.3 million in Q1 2026, $5.6 million in Q4 2025, and $1.2 million in Q3 2025.